Hans Link

发表

Neutralizing and binding anti‐interferon‐β (IFN‐β) antibodies. A comparison between IFN‐β‐1a and IFN‐β‐1b treatment in multiple sclerosis

P. Kivisäkk, H. Link, S. Fredrikson, 2000, European journal of neurology.

The complexicity of cytokine treatment in ongoing EAE induced with MBP peptide 68-86 in Lewis rats.

B. Wahrén, H. Link, Yu-min Huang, 2000, Clinical immunology.

Linomide (roquinimex) affects the balance between pro‐ and anti‐inflammatory cytokines in vitro in multiple sclerosis

G. Hedlund, H. Link, S. Fredrikson, 1998, Acta neurologica Scandinavica.

Augmented expression of tumour necrosis factor-alpha and lymphotoxin in mononuclear cells in multiple sclerosis and optic neuritis.

T. Olsson, H. Link, S. Fredrikson, 1996, Brain : a journal of neurology.

CD4+, CD8+, and CD4− CD8− T Cells in CSF and Blood of Patients with Multiple Sclerosis and Tension Headache

J. Correale, T. Olsson, V. Kostulas, 1990, Scandinavian journal of immunology.

Mononuclear cell types in cerebrospinal fluid and blood of patients with multiple sclerosis. Quantitation by immunoenzyme microassay with panel of monoclonal antibodies.

T. Olsson, J. Ernerudh, P. Forsberg, 1989, Archives of neurology.

High IL-6 and low IL-10 in the central nervous system are associated with protracted relapsing EAE in DA rats.

H. Link, A. Diab, M. Mustafa, 1997, Journal of neuropathology and experimental neurology.

Myelin antigen reactive T cells in cerebrovascular diseases

T. Olsson, V. Kostulas, H. Link, 1992, Clinical and experimental immunology.

Multiple sclerosis: the proinflammatory cytokines lymphotoxin-α and tumour necrosis factor-α are upregulated in cerebrospinal fluid mononuclear cells

H. Link, S. Fredrikson, M. Haglund, 1996, Journal of Neuroimmunology.

CSF neopterin as marker of disease activity in multiple sclerosis

P. Eneroth, H. Link, S. Fredrikson, 1987, Acta neurologica Scandinavica.

Multiple Sclerosis: Levels of Interleukin‐10‐Secreting Blood Mononuclear Cells are Low in Untreated Patients but Augmented During Interferon‐β‐1b Treatment

Link, Huang, V. Özenci, 1999, Scandinavian journal of immunology.

Tumor necrosis factor receptor-1 is critically involved in the development of experimental autoimmune myasthenia gravis.

F. Shi, H. Ljunggren, H. Link, 2000, International immunology.

Mucosal tolerance: a two-edged sword to prevent and treat autoimmune diseases.

H. Link, B. Xiao, Hans Link, 1997, Clinical immunology and immunopathology.

Intrathecal synthesis of IgG, IgA, IgM and IgD in untreated multiple sclerosis and controls

F. Lolli, H. Link, I. Halawa, 1989, Acta neurologica Scandinavica.

Cord blood contains cells secreting antibodies to nervous system components

H. Link, S. Fredrikson, J. Sun, 1991, Clinical and experimental immunology.

Glatiramer acetate reduces lymphocyte proliferation and enhances IL‐5 and IL‐13 production through modulation of monocyte‐derived dendritic cells in multiple sclerosis

G. Rosati, M. Pugliatti, S. Sotgiu, 2006, Clinical and experimental immunology.

Effects of Linomide on immune cells and cytokines inhibit autoimmune pathologies of the central and peripheral nervous system.

G. Hedlund, H. Link, B. Xiao, 2001, International immunopharmacology.

TGF-beta1 inhibits protracted-relapsing experimental autoimmune encephalomyelitis by activating dendritic cells.

H. Guo, H. Link, B. Xiao, 2000, Journal of autoimmunity.

Neutralising and binding anti-interferon-β-1 b (IFN-b-1 b) antibodies during IFN-β-1 b treatment of multiple sclerosis

P. Kivisäkk, H. Link, S. Fredrikson, 1997 .

Effect of monoamine reuptake inhibiting antidepressants on major histocompatibility complex expression on macrophages in normal rats and rats with experimental allergic neuritis (EAN).

T. Olsson, H. Link, E. Mix, 1994, Immunopharmacology.